1. Home
  2. AXR vs LUCD Comparison

AXR vs LUCD Comparison

Compare AXR & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMREP Corporation

AXR

AMREP Corporation

HOLD

Current Price

$19.24

Market Cap

127.3M

Sector

Real Estate

ML Signal

HOLD

Logo Lucid Diagnostics Inc.

LUCD

Lucid Diagnostics Inc.

HOLD

Current Price

$1.19

Market Cap

132.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXR
LUCD
Founded
1961
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.3M
132.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AXR
LUCD
Price
$19.24
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$3.94
AVG Volume (30 Days)
9.3K
684.1K
Earning Date
12-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.95
N/A
Revenue
$45,947,000.00
$4,399,000.00
Revenue This Year
$28.57
$11.18
Revenue Next Year
N/A
$147.43
P/E Ratio
$9.72
N/A
Revenue Growth
N/A
5.01
52 Week Low
$17.60
$0.80
52 Week High
$34.00
$1.80

Technical Indicators

Market Signals
Indicator
AXR
LUCD
Relative Strength Index (RSI) 40.04 60.34
Support Level $18.80 $1.12
Resistance Level $19.44 $1.15
Average True Range (ATR) 0.60 0.04
MACD 0.07 0.01
Stochastic Oscillator 35.93 96.67

Price Performance

Historical Comparison
AXR
LUCD

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Share on Social Networks: